Video by PCR via YouTube
Go to Source

Emanuele Barbato interviews Rasha Al-Lamee, the principal investigator of the ORBITA 2 trial, about the current role of percutaneous coronary intervention (PCI). Unlike ORBITA 1, ORBITA 2 focused on the effects of angioplasty as a monotherapy, without prior anti-angina treatment.
The results showed that angioplasty improved symptoms significantly, making patients more likely to be free from angina and anti-angina medication.
The study found that PCI benefits patients with significant coronary artery disease and typical angina symptoms, but is less effective for those with atypical symptoms.
Watch the video for more details!

This video was filmed during #EuroPCR 2024.
See more videos here: https://www.pcronline.com/Cases-resources-images/Resources/Educational-interviews

#pci
#angina
#angioplasty
#cad

Go to Source